OBJECTIVE - A reduction of diabetes-related blindness was declared a p
rimary objective for Europe (St. Vincent Declaration). We collected da
ta about incidence rates of blindness in the diabetic population compa
red with the nondiabetic population. Up to now such data are scarce-ev
en worldwide. RESEARCH DESIGN AND METHODS - A complete list of newly r
egistered blindness allowance recipients was drawn up in the district
of Wurttemberg-Hohenzollern, Germany, between 1990 and 1993. From thes
e data, we estimated age-specific and standardized incidence rates of
blindness in the entire, the diabetic, and the nondiabetic population,
as well as relative and attributable risks due to diabetes. RESULTS -
There were 2,714 people meeting the inclusion criteria; 1,823 (67.2%)
were female and 781 (28.8%) had diabetes. In 318 subjects, diabetes w
as likely to be the only cause of blindness; in 192 subjects, it was o
ne of several contributory causes. Age of women was 73.9 +/- 19.4 year
s (mean +/- SD) and of men 63.3 +/- 25.5 years. Results standardized t
o the (West) German population are as follows: incidence rates (per 10
0,000 person-years): total population: 13.5; diabetic population: 60.6
; nondiabetic population: 11.6; relative risk: 5.2; attributable risk
among exposed: 0.81; and population attributable risk: 0.14. The relat
ive risks decreased considerably with increasing age. When the study i
s repeated to monitor the St. Vincent targets, a reduction in the inci
dence rate of blindness in the diabetic population by 17% will be dete
cted with 95% power. CONCLUSIONS - Great relative and attributable ris
ks, especially in younger age-groups, indicate the need for increased
attention to preventive measures for microvascular complications.